|
Session Title: Stakeholder Values in Policy Evaluation: Working to Improve Public Health Policy at the Centers for Disease Control and Prevention
|
|
Panel Session 457 to be held in Pacific A on Thursday, Nov 3, 4:30 PM to 6:00 PM
|
|
Sponsored by the Advocacy and Policy Change TIG
and the Presidential Strand
|
| Chair(s): |
| Erika Fulmer, Centers for Disease Control and Prevention, efulmer@cdc.gov
|
| Discussant(s):
|
| Karen Debrot, Centers for Disease Control and Prevention, kdebrot@cdc.gov
|
| Abstract:
How do stakeholders value a policy? How does their valuing affect policy implementation, the organization of groups during adoption and enforcement, and the resulting health behaviors of individuals? This panel examines how three Divisions of the U.S. Centers for Disease Control and Prevention (CDC) conduct policy evaluation with stakeholders. The panelists will highlight methods to understand the values placed on policy formation and implementation, as well as how these values influence identification and prioritization of policy outcomes. The session will highlight lessons learned by CDC evaluators within chronic disease and injury prevention programs at the local, state, and national levels. Focused panel discussion will demonstrate how stakeholder engagement throughout policy evaluation can guide advocacy and policy planning, generate promising practices for policy implementation, and improve monitoring of policy outcomes.
|
|
Identifying Facilitators and Barriers to Implementing Policy, Environmental, and System Changes: Lessons Learned from Comprehensive Cancer Control Policy Taskforces
|
| Angela Moore, Centers for Disease Control and Prevention, armoore@cdc.gov
|
| Staci Lofton, Centers for Disease Control and Prevention, slofton@cdc.gov
|
| Julie Townsend, Centers for Disease Control and Prevention, jtownsend@cdc.gov
|
| Annette Gardner., Centers for Disease Control and Prevention, akg4@cdc.gov
|
|
In 2010, the Division of Cancer Prevention and Control (DCPC) at Centers for Disease Control and Prevention (CDC) provided additional competitive funding to 13 of the 69 CDC-funded National Comprehensive Cancer Control Programs (NCCCP) to advance their cancer prevention efforts by implementing policy, system, and environmental change strategies for sustainable cancer control. These funded entities will convene or enhance existing taskforces to develop a policy agenda that will impact the three cancers with the highest burden within their respective areas. An environmental scan of existing relevant efforts was conducted to identify both facilitators and barriers that contribute to the taskforce's success of influencing policy, systems, and environmental (PSE) change. Environmental scan methodology includes a review of the literature, internet search of grey literature, and key informant interviews. The results of the environmental scan will inform the development of an evaluation plan that will assess the processes and outcomes of NCCCP.
|
|
|
Valuing Stakeholder Values: A Case Study Approach to Evaluating "Return to Play Legislation" in Massachusetts and Washington
|
| Sue Lin Yee, Centers for Disease Control and Prevention, sby9@cdc.gov
|
| Howard Kress, Centers for Disease Control and Prevention, hkress@cdc.gov
|
| David Guthrie, Centers for Disease Control and Prevention, dguthrie@cdc.gov
|
| Elizabeth Zurick, Centers for Disease Control and Prevention, egf3@cdc.gov
|
| Rebecca Greco Kone, Centers for Disease Control and Prevention, ftm1@cdc.gov
|
|
Annually, over 3.8 million sports and recreation-related concussions occur in the United States. Youth athletes represent a large portion of the injured, and some obtain catastrophic injuries or die due to improper evaluation or management. Currently, 9 states have passed laws that require the education of key stakeholders and list requirements about removal from and return to play. To provide practice-based guidance to states considering similar legislation, the CDC National Center for Injury Prevention and Control is conducting an evaluation of the "return to play" laws in Washington and Massachusetts. This presentation will examine how values shape the participation of key stakeholders--athletes, public health practitioners, educators, and coaches--in the implementation of each state's legislation. Discussion will address unintended consequences, barriers to implementation, and offer suggestions for utilizing stakeholder values to promote effective implementation that eventually leads to a reduction in youth concussions.
| |
|
Advancing Tobacco Control Practice Through Policy Evaluation: Engaging Stakeholders to Set an Agenda for Reducing Tobacco Industry Influence
|
| Erika Fulmer, Centers for Disease Control and Prevention, efulmer@cdc.gov
|
| Kimberly Snyder, Oak Ridge Institute for Science and Education, kmsnyder@cdc.gov
|
| Martha Engstrom, Centers for Disease Control and Prevention, mengstrom@cdc.gov
|
| Shanta Dube, Centers for Disease Control and Prevention, sdube@cdc.gov
|
|
CDC's Office on Smoking and Health (OSH) is working with state and national partners to reframe the scope and application of key outcome indicators (KOI) for policy evaluation. Recent changes in the ability of both federal and state governments to regulate tobacco provide new opportunities to limit tobacco industry influences. OSH proactively engaged tobacco control stakeholders to clarify the scope of the problem, offer suggestions for enhancing tobacco industry monitoring, and identify relevant evaluation opportunities and challenges. Using this information, OSH systematically applied a set of assessment criteria to clarify high priority issues and worked to revamp its key outcome indicators to ensure that they remain timely and relevant for current and future policy evaluations. In this presentation, we describe the methods used to capture stakeholder input, the implicit and explicit values applied in selecting high priority issues, and the process for incorporating the information into tobacco policy evaluation.
| |